Contenu

x

Moteur de recherche interne

Grenoble Excellence in neurodegeneration Grenoble Excellence in neurodegeneration

Accueil > Équipes de recherche > GIN

Accéder au plan complet du site

Equipes du GIN impliquées dans GREEN


Grenoble Institute of Neurosciences - GIN

Inserm U1216, Univ. Grenoble Alpes
> http://neurosciences.ujf-grenoble.fr

Annie ANDRIEUX

Team ‘Cytoskeleton and physiopathologies’. The team study cytoskeleton proteins in relation to psychiatric and cognitive disturbances in mouse models.

Isabelle ARNAL

Team ‘Cytoskeleton Structure and Dynamics’.  The team focuses on the effect of tau protein and its AD-causing mutations on cytoskeleton structure and dynamics.

Emmanuel BARBIER

Team ‘Functional Neuroimaging’. The team develops innovative techniques for image acquisition and treatment for MRI including myelin detection and cognitive impairments.

Alain BUISSON

Team ‘Synaptic dysfunctions and Neuropathies’. The team focuses using electrophysiological approaches on the synapse function and memory processes in health and AD. 

Olivier DAVID

Team ‘Neuromodulation and brain function’. The Team studies neuronal networks and their alteration in neurological and psychiatric conditions and how stimulation (DBS, magnetic stimulations…) can restore such networks.

Francois ESTEVE

Team ‘Synchrotron radiation and Medical Research’. The team uses physical properties of synchrotron radiation fior therapeutic and diagnostic applications such as metals in PD. 

Sandrine HUMBERT

Team ’Neuronal progenitors and Brain Pathologies’. The teams focus on understanding the consequences of neurodevelopmental alterations on the pathophysiological progression of neurodegenerative diseases.

Rémy SADOUL

Team Plasticity and Neurodegeneration’. The teams focus on understanding the role of endosomal proteins in the pathophysiological mechanisms of neurodegeneration including AD.

Frédéric SAUDOU

Team ’Intracellular Dynamics and Neurodegeneration’. The teams focus on understanding the role of organelles trafficking (mostly axonal transport) in relation to energetic metabolism and neuronal survival in Huntington’s disease but also in AD.


Mise à jour le 7 avril 2016

Membres
Associés renforcés
Associés simples